Clinical Trial Update: Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of everolimus with paclitaxel and carboplatin in metastatic melanoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Everolimus (everolimus)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Metastatic Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2014-03-26